Literature DB >> 227921

Improved indirect hemagglutination test for cytomegalovirus using human O erythrocytes in lysine.

A S Yeager.   

Abstract

A modified indirect hemagglutination test for cytomegalovirus antibodies is described in which glutaraldehyde-fixed human O cells, rather than sheep cells, are used. Nonspecific hemagglutination was reduced by use of the optimal tannic acid concentration for each cell batch and the addition of 0.1 M lysine to the phosphate-buffered saline in which the fixed, tanned, sensitized cells were resuspended for use in the test. Three of 349 sera showed nonspecific hemagglutination by this technique. Antigen made by freezing phosphate-buffered saline (pH 7.2) over an infected monolayer can be used at dilutions of 1:8 to 1:15. Fixed, tanned, sensitized cells ready for use in the test can be stored in liquid nitrogen for up to 8 months. Use of cryoprotectants and washing after thawing is unnecessary. Simplification of the assay permits one person to screen 300 sera in 1 day or to determine the immune status of a potential donor or recipient in 45 min after the test is set up. The modified assay compares favorably in sensitivity with the complement fixation test and with previously described methods for performing the indirect hemagglutination test.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227921      PMCID: PMC273094          DOI: 10.1128/jcm.10.1.64-68.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  THE INCIDENCE OF INFECTION WITH CYTOMEGALOVIRUS IN A NORMAL POPULATION. A SEROLOGICAL STUDY IN GREATER LONDON.

Authors:  H STERN; S D ELEK
Journal:  J Hyg (Lond)       Date:  1965-03

2.  Analysis of antibody assay methods and classes of viral antibodies in serodiagnosis of cytomegalovirus infection.

Authors:  N E Cremer; M Hoffman; E H Lennette
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

3.  Clinical manifestations of renal allograft derived primary cytomegalovirus infection.

Authors:  R F Betts; R B Freeman; R G Douglas; T E Talley
Journal:  Am J Dis Child       Date:  1977-07

4.  Comparative activity of immunofluorescent antibody and complement-fixing antibody in cytomegalovirus infection.

Authors:  R F Betts; S D George; R B Rundell; R B Freeman; R G Douglas
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

5.  Anti-complement immunofluorescence test for antibodies to human cytomegalovirus.

Authors:  J D Kettering; N J Schmidt; D Gallo; E H Lennette
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

6.  A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts.

Authors:  P E Neiman; W Reeves; G Ray; N Flournoy; K G Lerner; G E Sale; E D Thomas
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

7.  The correlation of maternal cytomegalovirus infection during varying stages in gestation with neonatal involvement.

Authors:  G R Monif; E A Egan; B Held; D V Eitzman
Journal:  J Pediatr       Date:  1972-01       Impact factor: 4.406

8.  Transfusion-acquired cytomegalovirus infection in newborn infants.

Authors:  A S Yeager
Journal:  Am J Dis Child       Date:  1974-10

9.  Polyacrylamide-protein immunoadsorbents prepared with glutaraldehyde.

Authors:  T Ternynck; S Avrameas
Journal:  FEBS Lett       Date:  1972-06-01       Impact factor: 4.124

10.  Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections.

Authors:  S Stagno; D W Reynolds; C S Amos; A J Dahle; F P McCollister; I Mohindra; R Ermocilla; C A Alford
Journal:  Pediatrics       Date:  1977-05       Impact factor: 7.124

View more
  8 in total

1.  Detection of cytomegalovirus antibody with latex agglutination.

Authors:  S P Adler; M McVoy; V G Biro; W J Britt; P Hider; D Marshall
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

2.  Cytomegalovirus antigenic heterogeneity can cause false-negative results in indirect hemagglutination and complement fixation antibody assays.

Authors:  R G Faix
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

3.  Detection of cytomegalovirus antibody with two commercially available assays, an indirect hemagglutination test and an enzyme immunosorbent assay.

Authors:  S H Cheeseman; G V Doern; R A Ferriani; M W Keville; B R McGraw; J A Stewart
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

4.  Freeze-dried erythrocytes for an indirect hemagglutination test for detection of cytomegalovirus antibodies.

Authors:  N Cabau; R Crainic; C Duros; G Denoyel; A Gaspar; C Bronnert; A Boué; F Horodniceanu
Journal:  J Clin Microbiol       Date:  1981-06       Impact factor: 5.948

5.  Anticomplement immunofluorescence test that uses isolated fibroblast nuclei for detection of antibodies to human cytomegalovirus.

Authors:  L Mintz; R C Miner; A S Yeager
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

6.  Immunity to human cytomegalovirus measured and compared by complement fixation, indirect fluorescent-antibody, indirect hemagglutination, and enzyme-linked immunosorbent assays.

Authors:  J A Brandt; J D Kettering; J E Lewis
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

7.  Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T M Bakir; H Stern; H Kangro; P D Griffiths; R B Heath
Journal:  J Clin Pathol       Date:  1982-12       Impact factor: 3.411

8.  Indirect hemagglutination test for pseudorabies antibody detection in swine.

Authors:  K Haffer; D P Gustafson; C L Kanitz
Journal:  J Clin Microbiol       Date:  1980-03       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.